[go: up one dir, main page]

GB9402011D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9402011D0
GB9402011D0 GB9402011A GB9402011A GB9402011D0 GB 9402011 D0 GB9402011 D0 GB 9402011D0 GB 9402011 A GB9402011 A GB 9402011A GB 9402011 A GB9402011 A GB 9402011A GB 9402011 D0 GB9402011 D0 GB 9402011D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9402011A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GB9402011A priority Critical patent/GB9402011D0/en
Publication of GB9402011D0 publication Critical patent/GB9402011D0/en
Priority to PCT/GB1995/000135 priority patent/WO1995021167A1/en
Priority to EP95906416A priority patent/EP0741723A1/en
Priority to CA002182197A priority patent/CA2182197A1/en
Priority to AU14614/95A priority patent/AU1461495A/en
Priority to JP7520436A priority patent/JPH09508409A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB9402011A 1994-02-02 1994-02-02 Therapeutic agents Pending GB9402011D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB9402011A GB9402011D0 (en) 1994-02-02 1994-02-02 Therapeutic agents
PCT/GB1995/000135 WO1995021167A1 (en) 1994-02-02 1995-01-24 Triazole derivatives
EP95906416A EP0741723A1 (en) 1994-02-02 1995-01-24 Triazole derivatives
CA002182197A CA2182197A1 (en) 1994-02-02 1995-01-24 Triazole derivatives
AU14614/95A AU1461495A (en) 1994-02-02 1995-01-24 Triazole derivatives
JP7520436A JPH09508409A (en) 1994-02-02 1995-01-24 Triazole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9402011A GB9402011D0 (en) 1994-02-02 1994-02-02 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9402011D0 true GB9402011D0 (en) 1994-03-30

Family

ID=10749754

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9402011A Pending GB9402011D0 (en) 1994-02-02 1994-02-02 Therapeutic agents

Country Status (6)

Country Link
EP (1) EP0741723A1 (en)
JP (1) JPH09508409A (en)
AU (1) AU1461495A (en)
CA (1) CA2182197A1 (en)
GB (1) GB9402011D0 (en)
WO (1) WO1995021167A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283018B6 (en) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Imidazole, triazole and tetrazole derivatives, process of their preparation, their use and pharmaceuticals based thereon
NZ251047A (en) * 1992-04-10 1996-09-25 Pfizer Acylaminoindole derivatives and medicaments
CA2138649A1 (en) * 1992-07-24 1994-02-03 Raymond Baker Imidazole, triazole and tetrazole derivatives
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme 4-substituted 1, 2, 4-triazole derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH09508409A (en) 1997-08-26
WO1995021167A1 (en) 1995-08-10
EP0741723A1 (en) 1996-11-13
CA2182197A1 (en) 1995-08-10
AU1461495A (en) 1995-08-21

Similar Documents

Publication Publication Date Title
GB9415996D0 (en) Therapeutic agents
GB9415997D0 (en) Therapeutic agents
GB9416189D0 (en) Therapeutic agents
GB9416162D0 (en) Therapeutic agents
GB9402641D0 (en) Therapeutic agents
GB9410031D0 (en) Therapeutic agents
GB9411955D0 (en) Therapeutic agents
GB9415575D0 (en) Therapeutic agents
ZA95742B (en) Therapeutic agents
GB9409264D0 (en) Therapeutic agents
GB9403639D0 (en) Therapeutic agents
GB9402011D0 (en) Therapeutic agents
GB9415553D0 (en) Therapeutic agents
GB9421331D0 (en) Therapeutic agents
GB9404540D0 (en) Therapeutic agents
GB9402017D0 (en) Therapeutic agents
GB9407032D0 (en) Therapeutic agents
GB9401642D0 (en) Therapeutic agents
GB9401639D0 (en) Therapeutic agents
GB9407189D0 (en) Therapeutic agents
GB9407236D0 (en) Therapeutic agents
GB9410027D0 (en) Therapeutic agents
GB9415576D0 (en) Therapeutic agents
GB9415556D0 (en) Therapeutic agents
GB9415552D0 (en) Therapeutic agents